Urinary tests have been used as noninvasive, cost-effective tools for screening, diagnosis
and monitoring of diseases since ancient times. As we progress through the 21st century …

Precision medicine is rapidly emerging as a strategy to tailor medical treatment to a small
group or even individual patients based on their genetics, environment and lifestyle …

Prostate cancer (PCa) is the second most diagnosed cancer in men worldwide. For its
screening, serum prostate specific antigen (PSA) test has been largely performed over the …

The development of non-invasive screening techniques for early cancer detection is one of
the greatest scientific challenges of the 21st century. One promising emerging method is the …

Prostate cancer (PCa) diagnosis with current biomarkers is difficult and often results in
unnecessary invasive procedures as well as over-diagnosis and over-treatment, highlighting …

Metabolic reprogramming has been suggested as a hallmark of cancer progression.
Metabolomic analysis of various metabolic profiles represents a powerful and technically …

Prostate cancer (PCa) is one of the most frequently diagnosed cancers and a leading cause
of death among men worldwide. Despite extensive efforts in biomarker discovery during the …

Introduction Metabolomics is an emerging approach for early detection of cancer. Along with
the development of metabolomics, high-throughput technologies and statistical learning, the …

Prostate cancer, a leading cause of cancer-related deaths worldwide, principally occurs in
over 50-year-old men. Nowadays there is urgency to discover biomarkers alternative to …

Impaired metabolism may play an important role in the pathogenesis of lethal prostate
cancer, yet there is a paucity of evidence regarding the association. We conducted a large …